68,96 %HPV prevalence was 68.96% among fifty-eight WLWH enrolled in the study.
Gaboninfection à HPVpublié 2025Diseases (Basel, Switzerland)PubMeddocument de 12 observations
Palier Gold : evidences validées mécaniquement, avec leur source primaire.
41 evidences · page 1 / 2
68,96 %HPV prevalence was 68.96% among fifty-eight WLWH enrolled in the study.
Gaboninfection à HPVpublié 2025Diseases (Basel, Switzerland)PubMeddocument de 12 observations
33,9 %Oral HPV prevalence was 33.9% among 61 unvaccinated men who have sex with men (MSM) taking preexposure prophylaxis (PrEP) in France.
Gaboninfection à HPVpublié 2019Open forum infectious diseasesPubMeddocument de 10 observations
The cumulative HPV viral loads of any HPV and high-risk HPV in ICC were significantly higher than those in CIN2/3 (p < 0.002 for any HPV; p = 0.02 for HR-HPV).
Gabonhigh-risk HPV · ICC · infection à HPV · lésions précancéreuses du col (CIN)publié 2025Health science reportsPubMeddocument de 3 observations
11 genotypesHPV genotyping revealed the presence of 11 distinct HPV genotypes: 16, 18, 33, 31, 56, 6, 66, 70, 35, 45 and 81.
Gaboninfection à HPVpublié 2016Infectious agents and cancerPubMeddocument de 3 observations
92,4 %At least one HPV was detected in 92.4% of 132 Gabonese patients with high-grade neoplastic lesions.
Gaboninfection à HPVpublié 2023Infectious agents and cancerPubMeddocument de 6 observations
0,74 %The overall HPV prevalence in head and neck cancer biopsies was 0.74%.
Gabonhead and neck cancers · infection à HPVobservé 2009-2017publié 2019Infectious agents and cancerPubMeddocument de 2 observations
60 %The rate of HPV integration in the host genome was 60% (3/5) for LSIL in an urban Gabonese population.
Gaboninfection à HPVpublié 2019Scientific reportsPubMeddocument de 7 observations
4,38 copies_per_10000_cellsThe cumulative viral loads of any HPV and HR-HPV possessed a good discriminatory ability to differentiate between CIN2/3 and ICC, with optimal cutoffs ranging from 4.38 to 4.85 copies per 10,000 cells.
GabonICC · infection à HPV · lésions précancéreuses du col (CIN)publié 2025Health science reportsPubMeddocument de 3 observations
24,8 %The prevalence of HR-HPV genotypes was 24.8% among 399 women in Gabon.
Gaboninfection à HPVobservé 2024publié 2024BMC women's healthPubMeddocument de 5 observations
0,977 correlation_coefficientHR-HPV viral load was significantly correlated with squamous cell inflammation (r = 0.977 and P = 0.001) among women in Gabon.
Gaboninfection à HPVobservé 2024publié 2024BMC women's healthPubMeddocument de 5 observations
68 %Cervical HPV prevalence was 68.0% among first-generation immigrant African women attending the Centre Hospitalier Régional of Orléans, France.
Gaboninfection à HPVpublié 2021Journal of immigrant and minority healthPubMeddocument de 9 observations
71,4 %The rate of HPV integration in the host genome was 71.4% (5/7) for HSIL in an urban Gabonese population.
Gaboninfection à HPVpublié 2019Scientific reportsPubMeddocument de 7 observations
85,7 %The rate of HPV integration in the host genome was 85.7% (6/7) for carcinomas in an urban Gabonese population.
Gaboninfection à HPVpublié 2019Scientific reportsPubMeddocument de 7 observations
47 biopsiesHPV-positive results were detected in 47 biopsies, including 12 cases of CIN2/3 and 35 cases of ICC (4 adenocarcinoma and 31 squamous cell carcinoma).
Gabonadenocarcinoma · ICC · infection à HPV · lésions précancéreuses du col (CIN) · squamous cell carcinomapublié 2025Health science reportsPubMeddocument de 3 observations
71,4 %The integrated form of HPV16 genotype was found in 71.4% of samples regardless of cytological grade in an urban Gabonese population.
Gaboninfection à HPVpublié 2019Scientific reportsPubMeddocument de 7 observations
72,6 %Among 73 HPV-infected women, 72.6% (53/73) were infected with at least one high-risk HPV.
Gaboninfection à HPVobservé 2010publié 2011Journal de gynecologie, obstetrique et biologie de la reproductioneurope_pmcdocument de 12 observations
68,6 %The majority of genital HPV-positive and genital HPV-negative women (68.6% and 68.7%, respectively) exhibited serum or cervicovaginal IgG to Gardasil-9® HR-HPV.
Gaboninfection à HPVpublié 2020PloS onePubMeddocument de 7 observations
7,7 %Highly oncogenic human papillomavirus (HPV) infections are responsible for 7.7% of cancers in developing countries, mainly cervical cancer.
Gaboncancer du col de l'utérus · infection à HPVpublié 2017Medecine et sante tropicalesPubMeddocument de 3 observations
54 %More than half (54.0%) of 50 anal swabs from men who have sex with men in Bamako, Mali were infected by at least one HPV genotype targeted by the Gardasil-9® vaccine.
Gaboninfection à HPVpublié 2021Infectious agents and cancerPubMeddocument de 10 observations
7,7 %Infections caused by high-risk human papillomavirus (HPV) are responsible for 7.7% of cancers in developing countries, mainly cervical cancer.
Gaboncancer du col de l'utérus · infection à HPVpublié 2017Expert review of anti-infective therapyPubMeddocument de 3 observations
44,57 %The Abbott RealTime High-Risk HPV test detected at least one HPV genotype in 44.57% of women regardless of the grade of cervical abnormalities.
Gaboninfection à HPVpublié 2017Virology journalPubMed
82,9 %The HPV detection rate was 82.9% among women with abnormal cytology.
Gaboninfection à HPVpublié 2016Infectious Agents and CancerOpenAlexdocument de 6 observationsDOI 10.1186/s13027-016-0098-1
31,2 %One-third (31.2%) of genital HPV-negative women did not show any serum and genital HPV-specific IgG.
Gaboninfection à HPVpublié 2020PloS onePubMeddocument de 7 observations
70 %The overall prevalence of anal HPV infection of any genotypes was 70.0% among 50 men who have sex with men in Bamako, Mali.
Gaboninfection à HPVpublié 2021Infectious agents and cancerPubMeddocument de 10 observations
24,3 %The prevalence of HPV infection among 300 women attending gynecological consultation in two health centers in Ouagadougou was 24.3% (73/300).
Gaboninfection à HPVobservé 2010publié 2011Journal de gynecologie, obstetrique et biologie de la reproductioneurope_pmcdocument de 12 observations
Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.